ALBIREO PHARMA, INC. (ALBO) has 18 open-market insider trades by 12 insiders since 2017. The most active filer is Jan Mattsson, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 10% Owner | — | 2 | $35.0M | 2022-10-13 |
| Ab Astrazeneca | 10% Owner | — | 1 | $10.7M | 2017-12-01 |
| Joseph Edelman | 10% Owner | — | 1 | $9.1M | 2018-01-25 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 1 | $5.4M | 2020-02-03 |
| Phase4 Ventures III L.P. | 10% Owner | — | 1 | $3.4M | 2018-01-30 |
| Jan Mattsson | CSO | — | 4 | $3.1M | 2023-03-02 |
| Martha J. Carter | — | — | 2 | $1.7M | 2023-03-02 |
| Jason Duncan | CLO | — | 2 | $774K | 2023-03-02 |
| Ronald Harold Wilfred Cooper | CEOPres | — | 1 | $92K | 2023-03-02 |
| Michelle Graham | CHRO | — | 1 | $78K | 2023-03-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ronald Harold Wilfred Cooper | President | Sell | $46K | 2023-01-23 |
| Pamela Stephenson | Chief Commercial Officer | Sell | $4K | 2023-01-23 |
| Jason Duncan | CLO | Sell | $10K | 2023-01-23 |
| Martha J. Carter | Chief Regulatory Officer | Sell | $5K | 2023-01-23 |
| Jan Mattsson | Chief Scientific Officer | Sell | $9K | 2023-01-23 |
| Simon N.r. Harford | CFO & Treasurer | Sell | $156K |
Companies that share insiders with ALBO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-01-19 |
| Martha J. Carter | Chief Regulatory Officer | Sell | $41K | 2023-01-19 |
| Jan Mattsson | CSO | Sell | $271K | 2023-01-19 |
| Pamela Stephenson | CCO | Sell | $156K | 2023-01-19 |
| Pamela Stephenson | Chief Commercial Officer | Sell | $9K | 2022-12-27 |
| Simon N.r. Harford | Treasurer | Sell | $2K | 2022-10-24 |
| Jason Duncan | CLO | Sell | $13K | 2022-10-24 |
| Jan Mattsson | Chief Scientific Officer | Sell | $4K | 2022-10-24 |
| Ronald Harold Wilfred Cooper | President | Sell | $18K | 2022-10-24 |
| Simon N.r. Harford | Treasurer | Sell | $2K | 2022-10-11 |